127 related articles for article (PubMed ID: 11339503)
1. Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis rat.
Uknis AB; DeLa Cadena RA; Janardham R; Sartor RB; Whalley ET; Colman RW
Inflamm Res; 2001 Mar; 50(3):149-55. PubMed ID: 11339503
[TBL] [Abstract][Full Text] [Related]
2. Involvement of endogenous kinins in the pathogenesis of peptidoglycan-induced arthritis in the Lewis rat.
Blais C; Couture R; Drapeau G; Colman RW; Adam A
Arthritis Rheum; 1997 Jul; 40(7):1327-33. PubMed ID: 9214434
[TBL] [Abstract][Full Text] [Related]
3. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
[TBL] [Abstract][Full Text] [Related]
4. Interactions between bradykinin (BK) and cell adhesion molecule (CAM) expression in peptidoglycan-polysaccharide (PG-PS)-induced arthritis.
Sainz IM; Uknis AB; Isordia-Salas I; Dela Cadena RA; Pixley RA; Colman RW
FASEB J; 2004 May; 18(7):887-9. PubMed ID: 15001555
[TBL] [Abstract][Full Text] [Related]
5. Potent, long-acting bradykinin antagonists for a wide range of applications.
Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat.
Dela Cadena RA; Stadnicki A; Uknis AB; Sartor RB; Kettner CA; Adam A; Colman RW
FASEB J; 1995 Mar; 9(5):446-52. PubMed ID: 7896018
[TBL] [Abstract][Full Text] [Related]
7. A new generation of bradykinin antagonists.
Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET
Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
9. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
10. Characterization of bradykinin B(2) receptor antagonists in human and rat urinary bladder.
Meini S; Patacchini R; Giuliani S; Lazzeri M; Turini D; Maggi CA; Lecci A
Eur J Pharmacol; 2000 Jan; 388(2):177-82. PubMed ID: 10666510
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats.
Stadnicki A; Sartor RB; Janardham R; Majluf-Cruz A; Kettner CA; Adam AA; Colman RW
FASEB J; 1998 Mar; 12(3):325-33. PubMed ID: 9506476
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.
Espinola RG; Uknis A; Sainz IM; Isordia-Salas I; Pixley R; DeLa Cadena R; Long W; Agelan A; Gaughan J; Adam A; Colman RW
Am J Pathol; 2004 Sep; 165(3):969-76. PubMed ID: 15331420
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists.
Gama Landgraf R; Sirois P; Jancar S
Eur J Pharmacol; 2003 Jan; 460(1):75-83. PubMed ID: 12535863
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin.
Spragg J; Vavrek RJ; Stewart JM
Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073
[TBL] [Abstract][Full Text] [Related]
15. Effect of a kinin B2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats.
Santos DR; Calixto JB; Souza GE
Br J Pharmacol; 2003 May; 139(2):271-8. PubMed ID: 12770932
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats.
Stadnicki A; Sartor RB; Janardham R; Stadnicka I; Adam AA; Blais C; Colman RW
Gut; 1998 Sep; 43(3):365-74. PubMed ID: 9863482
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
[TBL] [Abstract][Full Text] [Related]
19. [Bradykinin antagonist: current status and perspective].
Hirayama Y; Kayakiri H
Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):45-53. PubMed ID: 11862756
[TBL] [Abstract][Full Text] [Related]
20. Plasma extravasation mediated by lipopolysaccharide-induction of kinin B1 receptors in rat tissues.
Wille PR; Vitor R; Gabilan NH; Nicolau M
Mediators Inflamm; 2001 Jun; 10(3):163-7. PubMed ID: 11545253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
